Sharps Compliance Corp

Sharps Compliance — Investor Presentation (July 2007)

21 slides from Sharps Compliance's investor presentation, Jul 11, 2007

  1. Slide 1: Sharps Compliance Investor Presentation July 2007

    Sharps Compliance Defining Change Through Innovation Investor Presentation July 2007 SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “estimate”, “anticipate”, “project” and “expect” and similar expressions are in

  3. Slide 3: Sharps Compliance Corp.

    Sharps Compliance Corp. v OTC BB: SCOM.OB v Market capitalization* v 52-week range* v Recent price* Y Total shares outstanding Y Diluted shares outstanding v Avg. daily trading volume (3 mos.) v Insider ownership (excluding options) ¥ Fiscal Year-End * As of 7/09/07 a5 $38.4 million $3.99 - $0.80 $3

  4. Slide 4: Sharps Delivers Solutions

    Sharps Delivers Solutions > © aya j a FM Tracer® Sharps Disposal by Mail System® Internet-based tracking system Texas incineration facility Ea UNITED STATES POSTAL SERVICE «

  5. Slide 5: Cost effective, Convenient, Efficient, Proven

    v Cost effective v Convenient v Efficient v Proven

  6. Slide 6: $1 Billion Market

    $1 Billion Market Opportunity 9 to 10 2 billion used million syringes < 1% Market Penetration to Date Americans annually legally disposed of self-inject by SQG

  7. Slide 7: Forces Driving Change

    Forces Driving Change Government Regulations Non-Emergency Delivery California and Massachusetts Growing Retail Settings Growing Number of Injectable Drug Treatments Expanding Health Issues

  8. Slide 8: Strategy for Growth

    Strategy for Growth Our growth strategy is to aggressively pursue larger sales opportunities in key growth markets while leveraging our operating, service and administrative infrastructure to increase profitability and shareholder value.

  9. Slide 9: Key Growth Markets

    Key Growth Markets ' ‘4 ® 7 Pharmaceutical Manufacturers Commercial/ = Retail Industrial E = : = G4 Clinics/ s 4 Flu Shots Professional

  10. Slide 10: Revenue mix by market, Q3 FY2007 TTM

    Retail = 9.9% Commercial/ Industrial = 4.5% Hospitality = 6.9% Professional = 4.7% Others = 6.0% Pharmaceutical = 5.5% Agricultural = 4.7% Q3 FY2007 TTM Revenue = $11.8M Home Healthcare = 57.8%

  11. Slide 11: Filling the Pipeline

    Filling the Pipeline 6 Direct Sales: Strong Targeted ao. Regional and telesales Internet pisttibutor ; target market approach Marketing Pp: focused v Recent improvements: v New Senior V.P. with pharmaceutical and managed care background v Strengthened inside and telemarketing sales efforts

  12. Slide 12: Solid Business Model

    Solid Business Model Solid, Experienced Management Strong Margins First 15-40% Mover Quarterly Advantage Early Revenue Market Srowth Cie Penetration Revenue Business Model Building Blocks

  13. Slide 13: Financial Highlights

    Sharps Compliance Defining Change Through Innovation Financial Highlights SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™

  14. Slide 14: Rapid Revenue Growth

    Rapid Revenue Growth ($ in thousands) Customer Billings 2 Quarterly Trend $11,774 $10,563 $9,289 $8,419 $8,619 $9,001 $6,513 $7,830 9 SH PP SP OS ~~ se is PP PP POS AL eg fg f& SS KS © av < « < ee e

  15. Slide 15: Realizing Operating Leverage

    Realizing Operating Leverage Fiscal Year Operating Margin Operating Margin Quarterly Trend 9.9% 9.9% 4.3% S * Ss s ~ © r + : : : 1 é & . se se x os r os KS e e eg eS o< ¢ * Excludes $138,000 Q3 FY2007 special charge.

  16. Slide 16: Bottom-line Profitability

    Bottom-line Profitability ga) Vs ofim ($ in thousands) Fiscal Year Net Income Net Income Quarterly Trend $930 ¥ $382 $930 $118 $493 $329 J s s $1,278 e s M, 1 1 1 1 1 & & s Ss os ae Ss e e ay a Av gk « « < ee 7 e per share i * Excludes $138,000 Q3 FY2007 special charge.

  17. Slide 17: Cash and EBITDA

    (As of and for the period ending March 31, 2007) Cash and EBITDA cash (Third Quarter equivalents FYTD 2007)* * Computed as operating income for the nine months ended March 31, 2007 of $760,333 plus depreciation and amortization of $142,002 and a special charge of $138,000.

  18. Slide 18: Strategy and Outlook

    Sharps Compliance Defining Change Through Innovation Strategy and Outlook SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™

  19. Slide 19: Government regulations driving change

    Government regulations driving change Experienced management team Sales and marketing traction Market leader Lack of significant competition in SQG market Strong Board membership

  20. Slide 20: Leader in the Small Quantity Generator market

    Leader in the Small Recognized name brand Value-added products and services Consistent high-quality performance Powerful operating leverage Developing strong, nationwide customer base

  21. Slide 21: Sharps Compliance

    Sharps Compliance Defining Change Through Innovation Investor Presentation July 2007 SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™

Sharps Compliance — Investor Presentation (July 2007) on 6ix